Biomm S.A. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was BRL 118.19 million compared to BRL 104.95 million a year ago. Net loss was BRL 81.14 million compared to BRL 92.56 million a year ago.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
14.22 BRL | -13.08% |
|
+2.30% | +146.02% |
05-16 | Biomm S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-18 | Biocon Signs Licensing and Supply Pact with Biomm to Commercialize Generic Ozempic in Brazil | MT |
1st Jan change | Capi. | |
---|---|---|
+146.02% | 326M | |
+16.27% | 122B | |
+21.43% | 116B | |
+22.18% | 27.03B | |
-21.86% | 20.36B | |
-16.89% | 16.43B | |
-18.50% | 15.91B | |
-44.74% | 15.6B | |
+61.65% | 14.94B | |
+2.88% | 13.59B |
- Stock Market
- Equities
- BIOM3 Stock
- News Biomm S.A.
- Biomm S.A. Reports Earnings Results for the Full Year Ended December 31, 2023